During allergic disease, leucocytes infiltrate the affected tissues an
d release their mediators and cytokines. In this way, the local inflam
matory process is induced and maintained. Basophilic granulocytes have
been demonstrated in lung and sputum of allergic asthmatics, in nasal
mucosa and secretion of allergic rhinitis patients, and in skin lesio
ns of atopic dermatitis patients. The number of basophils correlates w
ith the severity of the disease. Analysis of mediator profiles and cel
lular contents of lavages of nose, skin and lung during allergic late-
phase reactions (LPR) have demonstrated histamine, but not tryptase or
prostaglandin D-2. The histamine-containing cells have been character
ized as basophilic granulocytes, This indicates that infiltrating baso
phils but not mast cells are activated and release their inflammatory
contents in the LPR. We are interested in the cellular mechanisms that
determine the degranulation of basophils during LPR Basophil activato
rs, such as allergens and activated complement, are not present at the
se sites, However, cytokines that prime basophils but do not induce de
granulation, such as interleukin-5 (IL-5) and granulocyte/macrophage c
olony-stimulating factor (GM-CSF), have been detected at sites of LPR.
We have now observed that after emptying intracellular Ca2+ stores by
means of the Ca2+ adenosine triphosphatase (ATPase) inhibitor, thapsi
gargin, basophils become extremely sensitive to stimuli that do not af
fect the Ca2+ stores themselves but that induce degranulation, such as
the phorbolester, phorbol myristate acetate (PMA). The most interesti
ng finding was that although both thapsigargin and IL-3, IL-5 or GM-CS
F do not induce basophil degranulation by themselves, a 2 min preincub
ation of basophils with thapsigargin followed by addition of one of th
ese cytokines resulted in extensive histamine release: IL-3 induced 71
+/-7% histamine release (conc1/2max 6 pM), IL-5 induced 43+/-8% histam
ine release (conc1/2max 41 pM) and GM-CSF induced 57+/-10% histamine r
elease (conc1/2max 140 pM). Interestingly, the effect of thapsigargin
could be mimicked by platelet-activating factor (PAF) (range 10(-9) to
10(-6) M), although to a lesser extent. Our results indicate that bas
ophil degranulation in tissues during late-phase reactions might be ca
used by a combination of mediators or cytokines depleting Ca2+ stores,
as platelet-activating factor or thapsigargin do, concurrent with act
ivation by interleukin-3, interleukin-5 or granulocyte/macrophage colo
ny-stimulating factor, The response of the basophils towards these cyt
okines might also be influenced by cell adhesion events, such as bindi
ng of basophils via integrins. This is the subject of further study.